209 related articles for article (PubMed ID: 36164395)
1. TUG1/MAZ/FTH1 Axis Attenuates the Antiglioma Effect of Dihydroartemisinin by Inhibiting Ferroptosis.
Gong H; Gao M; Lin Y; Liu J; Hu Z; Liu J
Oxid Med Cell Longev; 2022; 2022():7843863. PubMed ID: 36164395
[TBL] [Abstract][Full Text] [Related]
2. Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells.
Chen Y; Mi Y; Zhang X; Ma Q; Song Y; Zhang L; Wang D; Xing J; Hou B; Li H; Jin H; Du W; Zou Z
J Exp Clin Cancer Res; 2019 Sep; 38(1):402. PubMed ID: 31519193
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancerthrough inhibiting GPX4 and enhancing ROS.
Han N; Li LG; Peng XC; Ma QL; Yang ZY; Wang XY; Li J; Li QR; Yu TT; Xu HZ; Xu X; Chen X; Wang MF; Li TF
Eur J Pharmacol; 2022 Mar; 919():174797. PubMed ID: 35122867
[TBL] [Abstract][Full Text] [Related]
4. Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition.
Yi R; Wang H; Deng C; Wang X; Yao L; Niu W; Fei M; Zhaba W
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32452511
[TBL] [Abstract][Full Text] [Related]
5. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism.
Du J; Wang X; Li Y; Ren X; Zhou Y; Hu W; Zhou C; Jing Q; Yang C; Wang L; Li H; Fang L; Zhou Y; Tong X; Wang Y
Cell Death Dis; 2021 Jul; 12(7):705. PubMed ID: 34262021
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin prompts amplification of photodynamic therapy-induced reactive oxygen species to exhaust Na/H exchanger 1-mediated glioma cells invasion and migration.
Hou K; Liu J; Du J; Mi S; Ma S; Ba Y; Ji H; Li B; Hu S
J Photochem Photobiol B; 2021 Jun; 219():112192. PubMed ID: 34000476
[TBL] [Abstract][Full Text] [Related]
7. Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response‑induced upregulation of CHAC1 expression.
Wang Z; Li M; Liu Y; Qiao Z; Bai T; Yang L; Liu B
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34558645
[TBL] [Abstract][Full Text] [Related]
8. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
[TBL] [Abstract][Full Text] [Related]
9. DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin.
Du J; Wang T; Li Y; Zhou Y; Wang X; Yu X; Ren X; An Y; Wu Y; Sun W; Fan W; Zhu Q; Wang Y; Tong X
Free Radic Biol Med; 2019 Feb; 131():356-369. PubMed ID: 30557609
[TBL] [Abstract][Full Text] [Related]
10. Dihydroartemisin inhibits glioma invasiveness via a ROS to P53 to β-catenin signaling.
Que Z; Wang P; Hu Y; Xue Y; Liu X; Qu C; Ma J; Liu Y
Pharmacol Res; 2017 May; 119():72-88. PubMed ID: 28111262
[TBL] [Abstract][Full Text] [Related]
11. Dihydroartemisinin inhibits the growth of pancreatic cells by inducing ferroptosis and activating antitumor immunity.
Zhang H; Zhuo Y; Li D; Zhang L; Gao Q; Yang L; Yuan X
Eur J Pharmacol; 2022 Jul; 926():175028. PubMed ID: 35569552
[TBL] [Abstract][Full Text] [Related]
12. The RNA-binding protein fragile-X mental retardation autosomal 1 (FXR1) modulates glioma cells sensitivity to temozolomide by regulating ferroptosis.
Wei Y; Duan S; Gong F; Li Q
Biochem Biophys Res Commun; 2022 May; 603():153-159. PubMed ID: 35294905
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Combined Effect of Artemisinin and Ferroptosis Inducer RSL3 against
Huang M; Cao X; Jiang Y; Shi Y; Ma Y; Hu D; Song X
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613672
[No Abstract] [Full Text] [Related]
14. Dihydroartemisinin Triggers Ferroptosis in Multidrug-Resistant Leukemia Cells.
Zhang X; Ai Z; Zhang Z; Dong R; Wang L; Jin S; Wei H
DNA Cell Biol; 2022 Aug; 41(8):705-715. PubMed ID: 35687364
[TBL] [Abstract][Full Text] [Related]
15. NSUN5-FTH1 Axis Inhibits Ferroptosis to Promote the Growth of Gastric Cancer Cells.
Su Y; Liu J; Zheng Z; Shi L; Huang W; Huang X; Ye C; Qi J; Wang W; Zhuang H
Cell Biochem Biophys; 2023 Sep; 81(3):553-560. PubMed ID: 37528314
[TBL] [Abstract][Full Text] [Related]
16. LncRNA CACNA1G-AS1 up-regulates FTH1 to inhibit ferroptosis and promote malignant phenotypes in ovarian cancer cells.
Jin Y; Qiu J; Lu X; Ma Y; Li G
Oncol Res; 2023; 31(2):169-179. PubMed ID: 37304234
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis.
Shi H; Xiong L; Yan G; Du S; Liu J; Shi Y
Front Mol Biosci; 2023; 10():1156062. PubMed ID: 37065442
[TBL] [Abstract][Full Text] [Related]
18. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2.
Cao Y; Chai W; Wang Y; Tang D; Shao D; Song H; Long J
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036375
[TBL] [Abstract][Full Text] [Related]
19. AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells.
Shao YY; Zhang TL; Wu LX; Zou HC; Li S; Huang J; Zhou HH
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208619
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis plays an essential role in the antimalarial mechanism of low-dose dihydroartemisinin.
Li S; Xu W; Wang H; Tang T; Ma J; Cui Z; Shi H; Qin T; Zhou H; Li L; Jiang T; Li C
Biomed Pharmacother; 2022 Apr; 148():112742. PubMed ID: 35228063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
